Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines

about

Ligand-enabled β-C-H arylation of α-amino acids using a simple and practical auxiliary.

P2860

Q40701143-E70C2B6A-2C30-4FFE-B4E2-15DAA7995F92

P2860

Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines

Item

http://www.wikidata.org/entity/Q40618990

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Analogues of doxanthrine revea ...... xahydrobenzo[a]phenanthridines

@en

type

Item

label

Analogues of doxanthrine revea ...... xahydrobenzo[a]phenanthridines

@en

prefLabel

Analogues of doxanthrine revea ...... xahydrobenzo[a]phenanthridines

@en

P1476

Analogues of doxanthrine revea ...... xahydrobenzo[a]phenanthridines

@en

P2093

Benjamin R Chemel

http://www.w3.org/2001/XMLSchema#string

David E Nichols

http://www.w3.org/2001/XMLSchema#string

Jose I Juncosa

http://www.w3.org/2001/XMLSchema#string

Juan Pablo Cueva

http://www.w3.org/2001/XMLSchema#string

Markus A Lill

http://www.w3.org/2001/XMLSchema#string

Val J Watts

http://www.w3.org/2001/XMLSchema#string

P2860

A neural substrate of prediction and reward

Parkinson's disease and D1 dopamine receptors

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys

trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist

Dihydrexidine--the first full dopamine D1 receptor agonist

(5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of it

A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia

The dopamine motor system.

8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.

9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.

P304

97-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJMECH.2011.11.039

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51977125

http://www.w3.org/2001/XMLSchema#string

P698

22204903

http://www.w3.org/2001/XMLSchema#string

P932

3264828

http://www.w3.org/2001/XMLSchema#string

Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines

about

P2860

P2860

Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932